• LAST PRICE
    42.1900
  • TODAY'S CHANGE (%)
    Trending Down-1.7000 (-3.8733%)
  • Bid / Lots
    42.1600/ 1
  • Ask / Lots
    42.3200/ 2
  • Open / Previous Close
    43.6600 / 43.8900
  • Day Range
    Low 42.1000
    High 43.8800
  • 52 Week Range
    Low 26.6100
    High 75.0167
  • Volume
    461,679
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 43.89
TimeVolumeGPCR
09:32 ET425843.405
09:34 ET168843.31
09:36 ET306142.83
09:38 ET153142.815
09:39 ET115542.6768
09:41 ET80042.78
09:43 ET165442.9
09:45 ET140042.44
09:48 ET278843
09:50 ET127542.94
09:52 ET227242.86
09:54 ET30042.68
09:56 ET897342.98
09:57 ET50042.97
09:59 ET114443.05
10:01 ET373943.29
10:03 ET105643.41
10:06 ET368943.82
10:08 ET55043.78
10:10 ET30043.855
10:12 ET403243.705
10:14 ET40043.69
10:15 ET401743.295
10:17 ET168342.88
10:19 ET173142.74
10:21 ET521342.7
10:24 ET69242.755
10:26 ET540242.855
10:28 ET810142.98
10:30 ET273242.7773
10:32 ET470042.95
10:33 ET845642.905
10:35 ET203742.94
10:37 ET124942.8
10:39 ET181742.985
10:42 ET185043.03
10:44 ET40043.04
10:46 ET20043
10:48 ET399542.89
10:50 ET207442.805
10:51 ET53242.8
10:53 ET370042.98
10:55 ET60043.085
10:57 ET85043.29
11:00 ET40043.19
11:02 ET30043.21
11:04 ET50043.17
11:06 ET98843.23
11:08 ET20043.19
11:09 ET102043.035
11:11 ET10043.07
11:13 ET20043.14
11:15 ET64543.14
11:18 ET10043.21
11:20 ET10043.2
11:24 ET130043.14
11:26 ET195043.06
11:27 ET516043.255
11:29 ET110043.38
11:31 ET198543.53
11:33 ET90043.715
11:36 ET231643.52
11:38 ET465343.46
11:40 ET66043.32
11:42 ET687543.55
11:44 ET324743.6
11:45 ET305243.525
11:47 ET76943.32
11:51 ET60043.3
11:54 ET50043.23
11:56 ET20043.31
11:58 ET149143.31
12:00 ET90343.04
12:03 ET59642.95
12:05 ET40043
12:07 ET10042.975
12:09 ET10043.06
12:12 ET51143.055
12:14 ET2270942.98
12:16 ET379842.675
12:18 ET10042.86
12:20 ET40042.775
12:21 ET30042.82
12:23 ET21642.66
12:25 ET10042.6
12:30 ET20042.635
12:32 ET10042.635
12:34 ET199442.77
12:36 ET10042.75
12:38 ET1129042.725
12:41 ET98042.685
12:43 ET212442.758
12:45 ET142242.96
12:48 ET125043
12:50 ET10043.03
12:52 ET10042.96
12:54 ET70043.065
12:56 ET73443.15
12:57 ET22543.05
12:59 ET95043.02
01:03 ET20043.08
01:06 ET37843.025
01:08 ET62243
01:10 ET637242.855
01:12 ET1098342.4
01:14 ET124242.425
01:15 ET10042.4363
01:17 ET10042.395
01:19 ET144742.61
01:21 ET70042.715
01:24 ET20042.73
01:26 ET32642.7
01:28 ET170342.72
01:30 ET176042.405
01:33 ET70042.41
01:35 ET300242.42
01:37 ET179242.18
01:39 ET288142.29
01:42 ET50042.22
01:44 ET16542.312
01:46 ET64942.215
01:48 ET620042.3819
01:50 ET760042.47
01:53 ET20042.565
01:55 ET229442.67
01:57 ET412542.786
02:00 ET101542.825
02:02 ET225142.625
02:04 ET220042.72
02:06 ET63542.695
02:08 ET161742.6459
02:09 ET60042.5759
02:11 ET260142.565
02:13 ET1549142.565
02:15 ET106042.61
02:18 ET215542.41
02:20 ET336542.36
02:22 ET30042.36
02:24 ET116142.33
02:26 ET306542.33
02:27 ET726442.37
02:29 ET72042.23
02:31 ET56742.31
02:33 ET101742.33
02:38 ET197442.17
02:40 ET110142.15
02:42 ET3944942.375
02:44 ET64242.275
02:45 ET285042.45
02:47 ET10042.36
02:49 ET94442.3607
02:51 ET288942.34
02:54 ET20042.2798
02:58 ET10042.235
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGPCR
Structure Therapeutics Inc
2.5B
-18.9x
---
United StatesEWTX
Edgewise Therapeutics Inc
2.5B
-17.9x
---
United StatesCGON
CG Oncology Inc
2.5B
-31.7x
---
United StatesIBRX
Immunitybio Inc
2.6B
-3.9x
---
United StatesVERA
Vera Therapeutics Inc
2.4B
-19.4x
---
United StatesSWTX
SpringWorks Therapeutics Inc
2.4B
-7.3x
---
As of 2024-10-01

Company Information

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.

Contact Information

Headquarters
611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Daniel Welch
Chief Executive Officer, Director
Raymond Stevens
Chief Financial Officer
Jun Yoon
Chief Technology Officer
Yingli Ma
Chief Scientific Officer
Xichen Lin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.5B
Revenue (TTM)
$0.00
Shares Outstanding
57.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.24
Book Value
$9.76
P/E Ratio
-18.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.